145 related articles for article (PubMed ID: 19645837)
1. Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology.
Smith PM; Stalin CE; Shaw D; Granger N; Jeffery ND
J Vet Intern Med; 2009; 23(3):520-6. PubMed ID: 19645837
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009-2017).
Song JH; Yu DH; Lee HC; Hwang TS; Kim YJ; An SJ; Jung DI
BMC Vet Res; 2020 Jun; 16(1):192. PubMed ID: 32532259
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011).
Barnoon I; Shamir MH; Aroch I; Bdolah-Abram T; Srugo I; Konstantin L; Chai O
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):116-24. PubMed ID: 26458162
[TBL] [Abstract][Full Text] [Related]
4. Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown aetiology in dogs.
Adamo PF; Rylander H; Adams WM
J Small Anim Pract; 2007 Sep; 48(9):486-96. PubMed ID: 17617166
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment with a combination of azathioprine and prednisone in dogs with meningoencephalomyelitis of undetermined etiology: 40 cases (2000-2007).
Wong MA; Hopkins AL; Meeks JC; Clarke JD
J Am Vet Med Assoc; 2010 Oct; 237(8):929-35. PubMed ID: 20946080
[TBL] [Abstract][Full Text] [Related]
6. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.
Menaut P; Landart J; Behr S; Lanore D; Trumel C
Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666
[TBL] [Abstract][Full Text] [Related]
7. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.
Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A
J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).
Kim SH; Oh YI; Park SM; An JH; Kim TH; Kim SS; Ah JG; Seo KW; Youn HY
BMC Vet Res; 2023 Dec; 19(1):269. PubMed ID: 38087262
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of cytarabine administered subcutaneously, combined with prednisone, in dogs with meningoencephalomyelitis of unknown etiology.
Pastina B; Early PJ; Bergman RL; Nettifee J; Maller A; Bray KY; Waldron RJ; Castel AM; Munana KR; Papich MG; Messenger KM
J Vet Pharmacol Ther; 2018 Oct; 41(5):638-643. PubMed ID: 29761906
[TBL] [Abstract][Full Text] [Related]
10. Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin.
Lowrie M; Thomson S; Smith P; Garosi L
Vet J; 2016 Jul; 213():1-5. PubMed ID: 27240905
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid monotherapy versus combined cytarabine continuous rate infusion and corticosteroid therapy in dogs with meningoencephalitis of unknown origin: A blinded, randomized, controlled trial.
Jones BS; Liebel FX; Fadda A; Martin S; Lawn R; Lazzerini K; Harcourt-Brown T
J Vet Intern Med; 2024; 38(3):1618-1625. PubMed ID: 38700360
[TBL] [Abstract][Full Text] [Related]
12. Long-term immunosuppressive therapy with cyclosporine plus prednisolone for necrotizing meningoencephalitis in a Pekingese dog.
Jung DI; Kim JW; Park HM
J Vet Med Sci; 2012 Jun; 74(6):765-9. PubMed ID: 22214856
[TBL] [Abstract][Full Text] [Related]
13. Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004).
Coates JR; Barone G; Dewey CW; Vitale CL; Holloway-Azene NM; Sessions JK
J Vet Intern Med; 2007; 21(1):100-6. PubMed ID: 17338156
[TBL] [Abstract][Full Text] [Related]
14. Ciclosporin treatment of suspected granulomatous meningoencephalomyelitis in three dogs.
Gnirs K
J Small Anim Pract; 2006 Apr; 47(4):201-6. PubMed ID: 16573763
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review.
Cornelis I; Van Ham L; Gielen I; De Decker S; Bhatti SFM
Vet J; 2019 Feb; 244():37-44. PubMed ID: 30825893
[TBL] [Abstract][Full Text] [Related]
16. Granulomatous meningoencephalomyelitis in dogs.
Adamo PF; Adams WM; Steinberg H
Compend Contin Educ Vet; 2007 Nov; 29(11):678-90. PubMed ID: 18210978
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on meningoencephalomyelitis of unknown origin.
Coates JR; Jeffery ND
Vet Clin North Am Small Anim Pract; 2014 Nov; 44(6):1157-85. PubMed ID: 25239815
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, diagnostic findings and outcome in dogs diagnosed withpresumptive spinal-only meningoen-cephalomyelitis of unknown origin.
Cornelis I; Volk HA; Van Ham L; De Decker S
J Small Anim Pract; 2017 Mar; 58(3):174-182. PubMed ID: 28267222
[TBL] [Abstract][Full Text] [Related]
19. Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin.
Stee K; Broeckx BJG; Targett M; Gomes SA; Lowrie M
Vet Rec; 2020 Nov; 187(11):e98. PubMed ID: 32862133
[TBL] [Abstract][Full Text] [Related]
20. Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Brady SL; Woodward AP; le Chevoir M
Aust Vet J; 2020 Oct; 98(10):491-498. PubMed ID: 32794230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
